120 related articles for article (PubMed ID: 8774066)
1. Nitrite/nitrate (NOX) and type II phospholipase A2, leukotriene B4, and platelet-activating factor levels in patients with septic shock.
Nakae H; Endo S; Inada K; Yaegashi Y; Takakuwa T; Yamada Y; Arakawa N; Suzuki T; Taniguchi S; Shimamura T; Ogawa M; Teraoka H
Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):131-9. PubMed ID: 8774066
[TBL] [Abstract][Full Text] [Related]
2. Relationships between plasma levels of type-II phospholipase A2, PAF-acetylhydrolase, leukotriene B4, complements, endothelin-1, and thrombomodulin in patients with sepsis.
Takakuwa T; Endo S; Nakae H; Suzuki T; Inada K; Yoshida M; Ogawa M; Uchida K
Res Commun Chem Pathol Pharmacol; 1994 Jun; 84(3):271-81. PubMed ID: 7938901
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of type II phospholipase A2 and nitrite/nitrate in patients with burns.
Yamada Y; Endo S; Kamei Y; Minato T; Yokoyama M; Taniguchi S; Nakae H; Inada K; Ogawa M
Burns; 1998 Sep; 24(6):513-7. PubMed ID: 9776089
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor and phospholipase A2 in patients with septic shock and trauma.
Sörensen J; Kald B; Tagesson C; Lindahl M
Intensive Care Med; 1994 Nov; 20(8):555-61. PubMed ID: 7706567
[TBL] [Abstract][Full Text] [Related]
5. Assessment of inflammatory mediators in patients with generalized peritonitis.
Kikuchi M; Endo S; Inada K; Inoue Y; Wakabayashi G; Ishikura H; Tanaka T
J Med; 1999; 30(3-4):245-58. PubMed ID: 17312678
[TBL] [Abstract][Full Text] [Related]
6. Platelet-activating factor (PAF) acetylhydrolase activity, type II phospholipase A2, and cytokine levels in patients with sepsis.
Endo S; Inada K; Yamashita H; Takakuwa T; Nakae H; Kasai T; Kikuchi M; Ogawa M; Uchida K; Yoshida M
Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):289-95. PubMed ID: 8008978
[TBL] [Abstract][Full Text] [Related]
7. PAF acetylhydrolase and arachidonic acid metabolite levels in patients with sepsis.
Takakuwa T; Endo S; Nakae H; Kikichi M; Inada K; Yoshida M
Res Commun Chem Pathol Pharmacol; 1994 Jun; 84(3):283-90. PubMed ID: 7938902
[TBL] [Abstract][Full Text] [Related]
8. SB 203347, an inhibitor of 14 kDa phospholipase A2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine endotoxin shock.
Marshall LA; Hall RH; Winkler JD; Badger A; Bolognese B; Roshak A; Flamberg PL; Sung CM; Chabot-Fletcher M; Adams JL
J Pharmacol Exp Ther; 1995 Sep; 274(3):1254-62. PubMed ID: 7562496
[TBL] [Abstract][Full Text] [Related]
9. Assessment of inflammatory cytokines, nitrate/nitrite, type II phospholipase A2, and soluble adhesion molecules in systemic inflammatory response syndrome.
Takakuwa T; Endo S; Inada K; Kasai T; Yamada Y; Ogawa M
Res Commun Mol Pathol Pharmacol; 1997 Oct; 98(1):43-52. PubMed ID: 9434314
[TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor and arachidonic acid metabolites in psoriatic inflammation.
Izaki S; Yamamoto T; Goto Y; Ishimaru S; Yudate F; Kitamura K; Matsuzaki M
Br J Dermatol; 1996 Jun; 134(6):1060-4. PubMed ID: 8763425
[TBL] [Abstract][Full Text] [Related]
11. The mouse plasma PAF acetylhydrolase: I. Characterization and properties.
Tsaoussis V; Vakirtzi-Lemonias C
J Lipid Mediat Cell Signal; 1994 May; 9(3):301-15. PubMed ID: 7921789
[TBL] [Abstract][Full Text] [Related]
12. Platelet activating factor and endotoxin increase the enzyme activity and gene expression of type II phospholipase A2 in the rat intestine. Role of polymorphonuclear leukocytes.
Tan XD; Wang H; Gonzalez-Crussi FX; Chang H; Gonzalez-Crussi F; Hsueh W
J Immunol; 1996 Apr; 156(8):2985-90. PubMed ID: 8609420
[TBL] [Abstract][Full Text] [Related]
13. Plasma concentrations of type II phospholipase A2, cytokines and eicosanoids in patients with burns.
Nakae H; Endo S; Inada K; Yamashita H; Yamada Y; Takakuwa T; Kasai T; Ogawa M; Uchida K
Burns; 1995 Sep; 21(6):422-6. PubMed ID: 8554682
[TBL] [Abstract][Full Text] [Related]
14. High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications.
Wu A; Hinds CJ; Thiemermann C
Shock; 2004 Mar; 21(3):210-21. PubMed ID: 14770033
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of type II phospholipase A2 and platelet-activating factor on Mac-1 surface expression and exocytosis of gelatinase granules in human neutrophils: evidence for the 5-lipoxygenase-dependent mechanism.
Takasaki J; Kawauchi Y; Masuho Y
J Immunol; 1998 May; 160(10):5066-72. PubMed ID: 9590257
[TBL] [Abstract][Full Text] [Related]
16. Relationship between plasma levels of type II phospholipase A2, PAF acetylhydrolase, endothelin-1, and thrombomodulin in patients with infected burns.
Takakuwa T; Endo S; Nakae H; Yamada Y; Inada K; Yoshida M; Ogawa M; Uchida K
Res Commun Mol Pathol Pharmacol; 1994 Dec; 86(3):335-40. PubMed ID: 7712109
[TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor and human thyroid cancer.
Denizot Y; Chianéa T; Labrousse F; Truffinet V; Delage M; Mathonnet M
Eur J Endocrinol; 2005 Jul; 153(1):31-40. PubMed ID: 15994743
[TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor and human meningiomas.
Denizot Y; De Armas R; Caire F; Pommepuy I; Truffinet V; Labrousse F
Neuropathol Appl Neurobiol; 2006 Dec; 32(6):674-8. PubMed ID: 17083481
[TBL] [Abstract][Full Text] [Related]
19. Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage.
Triggiani M; De Marino V; Sofia M; Faraone S; Ambrosio G; Carratù L; Marone G
Am J Respir Crit Care Med; 1997 Jul; 156(1):94-100. PubMed ID: 9230731
[TBL] [Abstract][Full Text] [Related]
20. Excretion of platelet activating factor-acetylhydrolase and phospholipase A2 into nasal fluids after allergenic challenge: possible role in the regulation of platelet activating factor release.
Touqui L; Herpin-Richard N; Gene RM; Jullian E; Aljabi D; Hamberger C; Vargaftig BB; Dessange JF
J Allergy Clin Immunol; 1994 Jul; 94(1):109-19. PubMed ID: 8027488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
